A SIMPLE KEY FOR ABBV-744 BRD4 INHIBITION IN CANCER CELL LINES UNVEILED

These side effects ended up notably milder when compared to an inhibitor of the two bromodomains. A detailed molecular Assessment also uncovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen TaylorOver-all, our latest work highlights the potential utilization of ARV-825 in combination